FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ — Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded global access to high-quality, low-cost ...
A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. A planning ...
In collaboration with the 29 th International Conference on Research in Computational Molecular Biology (RECOMB), Genome Research publishes a collection of novel computational methods and their ...
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...
FREMONT, Calif. and HOUSTON, Aug. 19, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG 100™ next-generation sequencing (NGS) platform, and Gene by Gene, a leading global provider of ...
SAN DIEGO--(BUSINESS WIRE)-- Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Genomic innovation offers opportunities in rapid diagnostics, scalable biomanufacturing, and precision therapies with advances in DNA extraction, pathogen detection, iPSC therapies, and DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results